ATG-F4 Composition for improving preventing or treating muscular disease including Lactobacillus reuteri ATG-F4

摘要

The present invention relates to a composition for preventing or treating sarcopenia, comprising a Lactobacillus reuteri ATG-F4 strain. More specifically, the strain increases a muscle mass of skeletal muscle to exhibit an effect of improving muscle rehabilitation and exercise ability, thereby being able to be used for the composition for preventing or treating sarcopenia or amyotrophia.